Expression Status of Rap1 Pathway-Related Genes in Liver Metastases Compared with Corresponding Primary Colorectal Cancer

被引:1
|
作者
Abbastabar, Maryam [1 ,2 ]
Allgayer, Heike [3 ]
Sepidarkish, Mahdi [4 ]
Sadeghi, Farzin [5 ]
Ghasemi, Maryam [6 ]
Pour-bagher, Roghayeh [5 ]
Parsian, Hadi [5 ]
机构
[1] Babol Univ Med Sci, Student Res Comm, Babol 4717647745, Iran
[2] Babol Univ Med Sci, Sch Med, Dept Clin Biochem, Babol 4717647745, Iran
[3] Heidelberg Univ, Med Fac Mannheim, Dept Expt Surg Canc Metastasis, D-68167 Mannheim, Germany
[4] Babol Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Babol 4717647745, Iran
[5] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Ganjafrooz St, Babol 4717647745, Iran
[6] Mazandaran Univ Med Sci, Immunogenet Res Ctr, Dept Pathol, Sari 48175866, Iran
关键词
colorectal cancer; colorectal cancer liver metastasis; NRAS; FGF1; KDR; NGF; MARKERS; PROFILE; NRAS; KDR;
D O I
10.3390/cancers16010171
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Understanding molecular networks of CRLM is an ongoing area of research. In this study, paired CRC tissue and adjacent noncancerous tissue from 15 non-metastatic CRC patients and paired CRC tissue and matched liver metastatic tissues from 15 CRLM patients along with their adjacent noncancerous tissues were evaluated. We assessed Rap1 pathway-related genes including NRAS, FGF-1, NGF, and KDR expression by qRT-PCR and their protein status by Western blot. In CRLM patients, NRAS, FGF1, and KDR mRNA and protein were expressed at higher levels in metastatic than in CRC primary tumor and adjacent noncancerous tissue (p < 0.05). In non-metastatic patients, NRAS, FGF1, KDR, and NGF gene expression did not differ between CRC primary tumor-and adjacent noncancerous tissue (p > 0.05). ROC curve analysis showed a reasonable diagnostic accuracy of NRAS, FGF1, KDR, and FGF for the discrimination of metastatic patients from non- metastatic ones on analysis of their primary tumors. The data suggest that further functional studies on Rap1-related genes' role in CRLM are needed. In conclusion, the present data broaden our knowledge about specific molecular characteristics of CRLM. An increased understanding of the molecular features of metastasis has the potential to create more successful treatment, or prevention, of metastasis, especially in multimodal primary tumor treatment.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The relationship between epidermal growth factor receptor (EGFR) mRNA levels and protein expression in primary colorectal cancer and corresponding liver metastases
    Kuramochi, H.
    Hayashi, K.
    Nakajima, G.
    Danenberg, K. D.
    Danenberg, P. V.
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Evaluation of concordance in KRAS mutation status between primary tumour and corresponding liver metastases after neoadjuvant treatment in 44 patients with colorectal cancer
    Cordoba, A.
    Amat, I.
    Guerrero, D.
    Gomez Dorronsoro, M. L.
    Suarez, J.
    Llanos, M. C.
    Mercado, M. R.
    De Lima, G.
    Alavarez, L.
    Larrinaga, B.
    VIRCHOWS ARCHIV, 2014, 465 : S222 - S222
  • [43] Mutation and Expression Profile of Primary Colorectal Cancer and Related Liver Metastasis
    Fadhil, W.
    Ibrahim, S.
    Ilyas, M.
    JOURNAL OF PATHOLOGY, 2012, 228 : S6 - S6
  • [44] Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas
    Ayaki, M
    Komatsu, K
    Mukai, M
    Murata, K
    Kameyama, M
    Ishiguro, S
    Miyoshi, J
    Tatsuta, M
    Nakamura, H
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 3106 - 3112
  • [45] Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours
    Ohrling, Katarina
    Edler, David
    Hallstrom, Marja
    Ragnhammar, Peter
    ANTICANCER RESEARCH, 2008, 28 (3B) : 1741 - 1747
  • [46] Increased Levels of Oxidative Damage in Liver Metastases Compared with Corresponding Primary Colorectal Tumors Association with Molecular Subtype and Prior Treatment
    van der Waals, Lizet M.
    Jongen, Jennifer M. J.
    Elias, Sjoerd G.
    Veremiyenko, Kateryna
    Trumpi, Kari
    Trinh, Anne
    Laoukili, Jamila
    Ubink, Inge
    Schenning-van Schelven, Susanne J.
    van Diest, Paul J.
    Rinkes, Inne H. M. Borel
    Kranenburg, Onno
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2369 - 2377
  • [47] ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases
    Verena Kirn
    Leonie Strake
    Fabinshy Thangarajah
    Lisa Richters
    Hannah Eischeid
    Ulrike Koitzsch
    Margarete Odenthal
    Jochen Fries
    Clinical & Experimental Metastasis, 2018, 35 : 707 - 712
  • [48] ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases
    Kirn, Verena
    Strake, Leonie
    Thangarajah, Fabinshy
    Richters, Lisa
    Eischeid, Hannah
    Koitzsch, Ulrike
    Odenthal, Margarete
    Fries, Jochen
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (07) : 707 - 712
  • [49] ERCC1 expression in advanced colorectal cancer and matched liver metastases
    Olsen, Laerke Muller
    Fiehn, Anne-Marie Kanstrup
    Hasselby, Jane Preuss
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [50] Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13
    Kawamata, Hiroshi
    Yamashita, Keishi
    Kojo, Ken
    Ushiku, Hideki
    Ooki, Akira
    Watanabe, Masahiko
    GENOMICS, 2015, 106 (02) : 71 - 75